Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

675
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
675
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Allergic Reactions02:06

Allergic Reactions

29.2K
Overview
29.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

815
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
815
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.3K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Humidifier lung and summer-type hypersensitivity pneumonitis in Japan: a nationwide retrospective observational study of clinical, radiological and pathological features.

BMJ open respiratory research·2026
Same author

Radiation-Associated Angiosarcoma of the Breast: A Case Report with Review of Reported Cases in Japan.

Surgical case reports·2026
Same author

Tepotinib Therapy for Advanced MET Exon 14 Skipping NSCLC With Non-Dialysis End-Stage Renal Disease: A Case Report.

Respirology case reports·2026
Same author

[EVALUATING CHALLENGES IN ALLERGY CARE: INSIGHTS FROM THE SAITAMA PREFECTURE TELEPHONE CONSULTATION PROGRAM FOR ALLERGIC DISEASES].

Arerugi = [Allergy]·2026
Same author

Successful Chemotherapy Induction Following Management of Obstructive Jaundice and Femoral Pathological Fracture in Extensive-Stage Small Cell Lung Cancer: A Case Report.

Respirology case reports·2026
Same author

Effects of sublingual allergen immunotherapy on non-targeted allergen-induced immune responses.

Allergology international : official journal of the Japanese Society of Allergology·2026

Related Experiment Video

Updated: Oct 12, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.6K

Allergen Immunotherapy in Asthma.

Kazuyuki Nakagome1,2, Makoto Nagata1,2

  • 1Department of Respiratory Medicine, Saitama Medical University, Saitama 350-0495, Japan.

Pathogens (Basel, Switzerland)
|November 27, 2021
PubMed
Summary
This summary is machine-generated.

Allergen immunotherapy (AIT) for house dust mite (HDM) allergy can improve asthma control and prevent new allergies. This specific treatment, including subcutaneous (SCIT) and sublingual (SLIT) forms, offers lasting benefits even after completion.

Keywords:
allergen immunotherapybronchial asthmasubcutaneous immunotherapysublingual immunotherapy

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.6K
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.2K

Related Experiment Videos

Last Updated: Oct 12, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.6K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.6K
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.2K

Area of Science:

  • Immunology
  • Allergology
  • Respiratory Medicine

Background:

  • Allergen immunotherapy (AIT) is a targeted treatment for allergic conditions.
  • Subtypes include subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
  • House dust mite (HDM) allergen immunotherapy shows promise in asthma management.

Purpose of the Study:

  • To evaluate the efficacy of HDM-AIT in alleviating asthma symptoms.
  • To assess the long-term effects and disease-modifying potential of AIT in asthma.
  • To explore AIT's role in preventing new allergen sensitization and managing comorbid allergic diseases.

Main Methods:

  • Administration of relevant allergens (HDM) via SCIT or SLIT.
  • Assessment of clinical symptoms, airway hyperresponsiveness, and medication requirements.
  • Evaluation of long-term outcomes, including remission rates and prevention of new sensitizations.

Main Results:

  • HDM-AIT alleviates asthma symptoms, reduces airway hyperresponsiveness, and lowers medication needs.
  • AIT effects persist for years post-treatment, potentially increasing asthma remission rates in children.
  • AIT can prevent new allergen sensitization and improve co-occurring allergic rhinitis, enhancing overall asthma control.

Conclusions:

  • HDM-AIT is effective for mild-to-moderate allergic asthma, offering sustained benefits and disease modification.
  • AIT may prevent asthma development in pollinosis and improve comorbidities like allergic rhinitis.
  • While HDM-SCIT is indicated for asthma, HDM-SLIT's use in asthma is expanding internationally and in Japan under specific conditions.